Dry eye syndrome may soon be treated with a new implant developed by a team led by researchers at Stanford University. The team identified the afferent neural pathway as being an excellent target for stimulation in order to activate tear production. They built a device that has platinum foil electrodes implanted under the inferior lacrimal gland, with an additional electrode reaching for the afferent ethmoid nerve. A remote control was used to activate the electric stimulation. The study was conducted with laboratory rabbits, some of which had long term wireless stimulators implanted to provide power.